Monoclonal antibodies could become additional migraine therapy option
Preventing or shortening the duration of migraine attacks – established drug treatment options and those that could shape future therapies were discussed at the Congress of European Academy of Neurology in Copenhagen.
Jun 1, 2016
0
2